Literature DB >> 18023509

Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.

Seishiro Naito1, Jun-ichi Maeyama, Takuo Mizukami, Motohide Takahashi, Isao Hamaguchi, Kazunari Yamaguchi.   

Abstract

Transcutaneous immunization (TCI) is a promising needle-free technique for vaccination. In this method, strong adjuvants, such as the cholera toxin, are generally crucial to elicit a robust immune response. Here, we showed that prolonged antigen presence on the skin of mice during TCI could effectively enhance the immune response. Substantial antigen-specific antibodies were produced in the sera of mice even after non-adjuvanted TCI when the antigen presence was for longer than 16 h. This non-adjuvanted TCI method was applied using the tetanus toxoid, and potent tetanus toxoid-specific antibodies were successfully induced in the sera of mice; they survived a lethal tetanus toxin challenge with no clinical signs. Thus, non-adjuvanted approach might be a possible option for TCI, and this method might improve the safety and practicality of transcutaneous vaccination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023509     DOI: 10.1016/j.vaccine.2007.10.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner.

Authors:  David Dunkin; M Cecilia Berin; Lloyd Mayer
Journal:  J Allergy Clin Immunol       Date:  2011-07-18       Impact factor: 10.793

Review 3.  Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.

Authors:  Baris E Polat; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2010-12       Impact factor: 6.648

4.  Potential mechanisms for the association between fall birth and food allergy.

Authors:  C A Keet; E C Matsui; J H Savage; D L Neuman-Sunshine; J Skripak; R D Peng; R A Wood
Journal:  Allergy       Date:  2012-04-19       Impact factor: 13.146

5.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

6.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.

Authors:  Sanna Nyström; Andreas Bråve; Tina Falkeborn; Claudia Devito; Björn Rissiek; Daniel X Johansson; Ulf Schröder; Satoshi Uematsu; Shizuo Akira; Jorma Hinkula; Steven E Applequist
Journal:  Vaccines (Basel)       Date:  2013-09-25

Review 8.  Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Authors:  Kazuhiko Matsuo; Sachiko Hirobe; Naoki Okada; Shinsaku Nakagawa
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.